DoJ Aims To ‘Do Something About’ Crime In FDA-Regulated Industries
This article was originally published in The Tan Sheet
Executive Summary
In a frank warning at a FDLI meeting, DoJ Director of Consumer Protection Michael Blume says the agency’s role is clear once it takes on a case investigated by FDA or FTC. Blume notes the dietary supplement category “has become something of an emphasis for us in the department.”
You may also be interested in...
DoJ Enlists Supporting Cast Against ‘Bad Actors’ On Supplement Stage
DoJ explores broader action and new avenues to rid the supplement market of noncompliant firms, Deputy Assistant Attorney General Olin says at a FDLI conference. CFSAN Deputy Director Michael Roosevelt says identification of unknown supplement ingredients is a 2016 priority.
DoJ Enlists Supporting Cast Against ‘Bad Actors’ On Supplement Stage
DoJ explores broader action and new avenues to rid the supplement market of noncompliant firms, Deputy Assistant Attorney General Olin says at a FDLI conference. CFSAN Deputy Director Michael Roosevelt says identification of unknown supplement ingredients is a 2016 priority.
Federal Sweep Nets 40 Criminal, Civil Cases For Spiked Supplements, Disease Claims
A deputy assistant attorney general clarifies that ongoing investigations target “unlawful makers and marketers of dietary supplements,” but DoJ and other agencies broadly warn the entire industry about the potential for additional criminal cases as well as civil complaints.